Shares of Dr Agarwal's Eye Hospital are trading at an all-time high on September 6

resr 5paisa Research Team

Last Updated: 16th December 2022 - 05:25 am

Listen icon

In the last three sessions, the stock delivered a return of 46%. 

Today on September 6, at 11:04 am, S&P BSE Sensex is at 59128.75 , 0.2% down on the day, while NIFTY50 is down 0.16% and trading at 17,637.65. Regarding Sectoral performance, Power and Utilities are the top performers, while IT is the top loser. 

Talking about stock-specific action, shares of Dr Agarwal's Eye Hospital Ltd are trading at their 52-week high and all-time high price. It is the top gainer among the S&P BSE group ‘X’ companies today. The stock surged about 14.59% on the day and is trading at Rs 1167.95, as of 11:04 am. The stock opened at Rs 1145, and so far, has made an intraday high and low of Rs 1195 and Rs 1067.3, respectively. 

Dr Agarwal's Eye Hospital Ltd share price is soaring today as the investors are rushing to buy the stock as it is the last date to be eligible for receiving a dividend payout from the company. The company had announced a dividend of Rs 3 per share with an ex-dividend date of September 6 and a record date of September 14. 

Dr Agarwal's Eye Hospital Ltd is a leading eye hospital chain in the state of Tamil Nadu. It has more than 20 centres located across the state. As per the FY22 period ending, the company has ROE and ROCE of 20% and 36%, respectively. 

In FY22, the company reported a net sale of Rs 201.21 crore, while generating a net profit of Rs 24.1 crore. In the last 10 years, the company has increased its net profit 12 times, from Rs 2 crore in FY12 to Rs 24 crore in FY22. 

On September 6, the stock is trading higher for the 3rd consecutive session. In these three sessions, the stock price has soared from Rs 800 to Rs 1167.95, delivering a return of 46%. 

The company has a market capitalisation of Rs 547 crore and is trading at a PE multiple of 14.12x

How do you rate this article?
Characters remaining (1500)

FREE Trading & Demat Account
+91
''
By proceeding, you agree to our T&Cs*
Mobile No. belongs to
hero_form

Indian Market Related Articles

Axis Momentum Fund – Direct (G) : NFO Details

by 5paisa Research Team 22nd Nov 2024

LIC Increases Stake in LTIMindtree to 7.03%

by 5paisa Research Team 22nd Nov 2024

Protean eGov Shares Dip 9% as NSE Plans Stake Sale

by 5paisa Research Team 22nd Nov 2024

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Want to Use 5paisa
Trading App?